| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.8M | +26.9% |
| SG&A Expense | $20.8M | +10.0% |
| Operating Income | -$68.7M | -21.2% |
| Income Tax | $0 | — |
| Net Income | -$67.1M | -18.4% |
| EPS (Basic) | -$1.78 | +25.8% |
| EPS (Diluted) | -$1.78 | +25.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.9M | +41.2% |
| Short-term Investments | $95.0M | +7.3% |
| Current Assets | $131.4M | +13.9% |
| Total Assets | $139.2M | +12.7% |
| Current Liabilities | $14.7M | +26.5% |
| Long-term Debt | $4.1M | — |
| Total Liabilities | $20.8M | +45.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.8M | -20.0% |
| Capital Expenditures | $410K | +3.3% |
| Investing Cash Flow | -$5.4M | -112.6% |
| Financing Cash Flow | $72.8M | — |
| Free Cash Flow | -$58.2M | -19.8% |
| Stockholders' Equity |
| $118.4M |
| +8.4% |